Benzoic acid, 4-amino-, 2-(diethylamino)ethyl ester, mixt. with 3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6-dione and 1-ethenyl-2-pyrrolidinone homopolymer (95017-34-8)

Identification
Name:	Benzoic acid, 4-amino-, 2-(diethylamino)ethyl ester, mixt. with 3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6-dione and 1-ethenyl-2-pyrrolidinone homopolymer
Synonyms:	impletol depot Bayer
CAS:	95017-34-8
Molecular Formula:	C₂₇H₃₉N₇O₅
Molecular Weight:	0
InChI:	InChI=1/C13H20N2O2.C8H10N4O2.C6H9NO/c1-3-15(4-2)9-10-17-13(16)11-5-7-12(14)8-6-11;1-10-4-9-6-5(10)7(13)12(3)8(14)11(6)2;1-2-7-5-3-4-6(7)8/h5-8H,3-4,9-10,14H2,1-2H3;4H,1-3H3;2H,1,3-5H2
Molecular Structure:
Properties
Flash Point:	179.8°C
Boiling Point:	373.6°Cat760mmHg
Density:	g/cm³
Flash Point:	179.8°C
Safety Data

Other Product

1H-Purine-2,6-dione,7-[2-(diethylamino)ethyl]-3,7-dihydro-3-[2-(3-nitrophenyl)ethyl]-1-propyl-8-(4-pyridazinylmethyl)-
1H-Purine-2,6-dione,1-[2-(diethylamino)ethyl]-7-(2,3-dihydroxypropyl)-3,7-dihydro-3-methyl-
1H-Purine-2,6-dione,1-[2-(diethylamino)ethyl]-3,7-dihydro-3-methyl-7-(phenylmethyl)-
pyridine-3-carboxylic acid - 7-[2-(diethylamino)ethyl]-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione (1:1)
Androst-4-en-3-one,17-hydroxy-,(17â)-,mixt. with 3,7-dihydro-7-(2-hydroxyethyl)-1,- 3-dimethyl-1H-purine-2,6-dione,3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6- dione,(17â)-10-ethyl-17-hydroxyestr-4-en- 3-one,4-hydroxy-R-[1-[(1-methyl-3-phenylpropyl) amino]ethyl]benzenemethanol hydrochloride and (17R)-19-norpregna-1,3,5(10)-trien-20-yne- 3,17-diol
Androst-4-en-3-one,17-hydroxy-,(17â)-,mixt. with 3,7-dihydro-7-(2-hydroxyethyl)-1,- 3-dimethyl-1H-purine-2,6-dione,3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6- dione,(17â)-10-ethyl-17-hydroxyestr-4-en- 3-one,4-hydroxy-R-[1-[(1-methyl-3-phenylpropyl) amino]ethyl]benzenemethanol hydrochloride and (17R)-19-norpregna-1,3,5(10)-trien-20-yne- 3,17-diol
4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid,3,3-dimethyl-7-oxo-6-[(phenoxyacetyl)- amino]-,(2S,5R,6R)-,mixt. with 4-amino-N-(6-methoxy-3-pyridazinyl)- benzenesulfonamide and 3,7-dihydro-1,3-dimethyl-1H-purine-2,6- dione
Morphinan-6-ol, 7,8-didehydro-4,5-epoxy-3-methoxy-17-methyl-, (5alpha,6alpha)-, phosphate (1:1) (salt), mixt. with 2-(acetyloxy)benzoic acid, 3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6-dione and 5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione
Benzeneacetic acid, alpha-hydroxy-alpha-phenyl-, 2-(diethylamino)ethyl ester, hydrochloride, mixt. with 5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione, 1-hexyl-3,7-dihydro-3,7-dimethyl-1H-purine-2,6-dione and N,N,4-trimethyl-gamma-phenylbenzenepropanamine hydrochloride
7-(3-bromo-4-methoxybenzyl)-1-ethyl-8-[(2-hydroxycyclopentyl)amino]-3-(2-hydroxyethyl)-3,7-dihydro-1H-purine-2,6-dione
3-Pyridinecarboxylic acid,compounds,compd. with 3,7-dihydro-7-[2-hydroxy-3-[(2- hydroxyethyl)methylamino]propyl]-1,3- dimethyl-1H-purine-2,6-dione (1:1),mixt. with pentosan sulfates
1H-Purine-2,6-dione,7-[2-(diethylamino)ethyl]-3,7-dihydro-8-[[1-(hydroxymethyl)propyl]amino]-1,3-dimethyl-,hydrochloride (1:1)
1H-Purine-2,6-dione,8-amino-7-[(3-bromo-4-methoxyphenyl)methyl]-1-ethyl-3,7-dihydro-3-(2-hydroxyethyl)-
Heparin, compd. with 7-(2-(diethylamino)ethyl)-3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione (1:1)
1H-Purine-2,6-dione,7-[4-[5-[2-(diethylamino)ethyl]-1,2,4-oxadiazol-3-yl]butyl]-3,7-dihydro-1,3-dimethyl-, (2Z)-2-butenedioate (1:1)
1H-Purine-2,6-dione,3,7-dihydro-1,3-dimethyl-7-[2-[4-(3-methylphenyl)-1-piperazinyl]ethyl]-
1H-Purine-2,6-dione,3,7-dihydro-7-[2-[4-(3-methoxyphenyl)-1-piperazinyl]ethyl]-1,3-dimethyl-
1H-Purine-2,6-dione,7-[2-[4-(3-chlorophenyl)-1-piperazinyl]ethyl]-3,7-dihydro-1,3-dimethyl-
1H-Purine-2,6-dione, 7-[2-(diethylamino)ethyl]-3,7-dihydro-3-methyl-
1H-Purine-2,6-dione, 7-[2-(diethylamino)ethyl]-3,7-dihydro-3-methyl-,monohydrochloride